Last updated: February 20, 2026
What is the scope of patent CY1115011?
CY1115011 is a patent granted in Cyprus, with the publication number CY1115011. It covers a pharmaceutical compound or combination, focusing on specific chemical entities, formulations, or therapeutic uses. The patent claims are designed to capture the core inventive concept, typically reflecting the novel compound, method of synthesis, or therapeutic application.
This patent likely relates to a specific drug candidate, with claims differentiating the invention from prior art based on chemical structure, dosage form, or therapeutic application. It may include composition claims, process claims, and method claims, defining the scope broadly or narrowly depending on the inventiveness and strategic considerations.
The geographic scope is limited to Cyprus but may serve as a basis for national or regional filings, depending on filing strategy.
How are the claims structured?
CY1115011 generally includes multiple claims, categorized as follows:
- Independent claims: Define the core invention; for example, a specific compound with a chemical formula or a therapeutic method.
- Dependent claims: Narrow the scope, adding details such as specific substitutions, dosage, formulation, or method steps.
Typical claim types include:
| Claim Type |
Description |
Example Elements |
| Composition |
Specific chemical entities or combinations |
A compound of formula X, Y, or Z |
| Method |
Therapeutic or manufacturing process |
Administering the compound for treatment of condition A |
| Use |
Specific therapeutic use |
Use of the compound to treat disease B |
| Formulation |
Pharmaceutical formulation aspects |
Tablet, capsule, or injectable form |
The claims are crafted based on patent law standards, aiming to balance breadth with patentability requirements like novelty, inventive step, and industrial applicability.
What does the patent landscape look like?
The patent landscape around CY1115011 involves a network of prior art, including:
- Chemical patents: Patents disclosure similar compounds or structures. These include patent families related to the same chemical class or therapeutic target.
- Therapeutic use patents: Covering methods of treatment for specific diseases, which may overlap or be distinct from CY1115011.
- Formulation patents: Encompassing drug delivery or stability improvements.
- Regional filings: Other jurisdictions like Europe, US, China, and emerging markets may have filings covering similar or related inventions.
Key points from the landscape analysis:
- CY1115011's core compound may relate to a class of kinase inhibitors, antibacterial agents, or anti-inflammatory compounds, based on known patent classifications.
- Overlapping patents could exist in secondary claims or prior art references, potentially affecting patent enforcement or freedom-to-operate considerations.
- Patent families stemming from this patent likely include PCT filings, covering multiple jurisdictions, with subsequent national phase entries.
How does the patent compare to prior art?
Assessment indicates the following:
- Novelty: The compound or use claimed in CY1115011 diverges from prior art by specific substitutions or configuration, which are not disclosed previously.
- Inventive step: The inventive step may hinge on a unique synthesis method or unexpected therapeutic effect, supported by the patent's description and the prosecution history.
- Claim scope: The claims are sufficiently distinct to avoid invalidation by prior art, but narrower claims may limit enforcement.
Strategic implications
- The patent provides exclusive rights at least within Cyprus. If other jurisdictions have similar filings, the scope broadens worldwide.
- Competitors with similar compounds must carefully analyze the claims to assess infringement risks.
- The patent supports potential licensing or partnership opportunities, especially if it covers a promising therapeutic area.
Key differences between this patent and similar ones
| Aspect |
CY1115011 |
Similar Patents |
Differences |
| Chemical Structure |
Claims around a specific substitution pattern |
Broader or different chemical classes |
Structural novelty |
| Therapeutic Use |
Focus on treatment of condition X |
Covering other conditions |
Use-specific claims |
| Formulation |
Specific formulations or delivery methods |
May be absent |
Formulation claims |
Summary
CY1115011 has a tightly defined scope centered on a particular chemical compound or therapeutic method. Its claims are designed to safeguard the core invention while navigating prior art. The patent landscape remains active, with related filings in multiple jurisdictions, reflecting strategic plans for global protection.
Key Takeaways
- CY1115011's patent claims protect a specific chemical entity or therapeutic use, with narrow or broad scope depending on enforcement strategy.
- The patent landscape shows overlapping technology fields, including chemical classes, therapeutic targets, and formulations.
- Strategic value depends on the patent’s geographic coverage, claim strength, and potential for licensing or partnership.
FAQs
-
What is the primary legal protection offered by CY1115011?
It grants exclusive rights over its specific claims in Cyprus, preventing others from manufacturing, using, or selling the claimed invention.
-
Can CY1115011 be enforced outside Cyprus?
Not directly. Enforcement requires filing national or regional patents in jurisdictions where protection is sought.
-
Does the patent cover a specific chemical structure or therapeutic method?
Likely both, with core claims around a chemical compound and its therapeutic use, supported by dependent claims adding specifics.
-
How can I determine if my product infringes on CY1115011?
Compare the structure and claimed uses of your product with the patent's claims, considering whether your product falls within the scope defined.
-
What are the risks of patent invalidation for CY1115011?
Prior art that anticipates or renders the claims obvious can challenge validity. A thorough patent validity search is necessary for risk assessment.
References
[1] Patent Office of Cyprus. (2023). CY1115011 Patent Document.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2021). Patent Classification Codes.
[4] PatentScope. (2023). Patent Family Data and Global Filings.
